TRxADE HEALTH, INC Quarterly Debt-to-equity in % from Q1 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TRxADE HEALTH, INC quarterly Debt-to-equity history and growth rate from Q1 2018 to Q2 2024.
  • TRxADE HEALTH, INC Debt-to-equity for the quarter ending June 30, 2024 was 75.4 %, a 92.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 75.4 -918 -92.4% Jun 30, 2024
Q1 2024 124 -177 -58.8% Mar 31, 2024
Q4 2023 266 +68.9 +34.9% Dec 31, 2023
Q3 2023 187 +64.1 +52% Sep 30, 2023
Q2 2023 993 +919 +1237% Jun 30, 2023
Q1 2023 301 +260 +637% Mar 31, 2023
Q4 2022 197 +173 +704% Dec 31, 2022
Q3 2022 123 +106 +629% Sep 30, 2022
Q2 2022 74.3 +60.1 +425% Jun 30, 2022
Q1 2022 40.8 +27 +196% Mar 31, 2022
Q4 2021 24.6 +10.4 +73.6% Dec 31, 2021
Q3 2021 16.9 -0.01 -0.06% Sep 30, 2021
Q2 2021 14.2 -10.3 -42.2% Jun 30, 2021
Q1 2021 13.8 -26.1 -65.4% Mar 31, 2021
Q4 2020 14.1 -59.7 -80.8% Dec 31, 2020
Q3 2020 16.9 -89.6 -84.1% Sep 30, 2020
Q2 2020 24.5 Jun 30, 2020
Q1 2020 39.8 Mar 31, 2020
Q4 2019 73.8 Dec 31, 2019
Q3 2019 106 Sep 30, 2019
Q2 2018 -326 Jun 30, 2018
Q1 2018 -238 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.